Sabby Capital: A NJ-based healthcare investment advisory firm.
Location
Upper Saddle River, NJ, US
Founded
2011
Sabby Capital is a New Jersey-based investment advisory firm specializing in the healthcare sector. The firm typically invests in later-stage rounds, including Series B, C, D, and post-IPO equity. Their investment focus spans various healthcare subsectors, with a particular emphasis on biotechnology and pharmaceutical companies.
Notable portfolio companies include Ardelyx, Blueprint Medicines, and Cidara Therapeutics. Sabby Capital has participated in significant funding rounds, with investments ranging from $14 million to $80 million. The firm's expertise in healthcare investing allows them to provide strategic guidance and support to their portfolio companies, helping them navigate the complex healthcare landscape.
Sabby Capital - Portfolio Snapshot
Portfolio activity breakdown across disclosed investments and stages
Portfolio Companies7
Current Portfolio Count6
Total Portfolio Exits1
Top Investment Stages
Series C3 (60.0%)
Series B1 (20.0%)
Series D1 (20.0%)
Stage Mix
Series C 60%Series B 20%Series D 20%
Concentration shown as share of disclosed investments by stage.
